Table 3.
P – value | OR | 95% CI | |
---|---|---|---|
Timing of Chemotherapy* | 0.001 | 3.123 | 1.605 – 6.078 |
| |||
Preoperative Chemotherapy | 0.137 | 1.875 | 0.819 – 4.292 |
| |||
Margin Status | 0.006 | 3.736 | 1.454 – 9.599 |
| |||
Pathologic Stage | |||
1 | 0.004 | 0.137 | 0.035 – 0.539 |
2 | 0.845 | 0.894 | 0.290 – 2.751 |
3 | 0.683 | 0.833 | 0.347 – 2.001 |
4 | 0.103 | 3.800 | 0.763 – 18.922 |
| |||
Comorbidity+ | 0.031 | 2.117 | 1.069 – 4.195 |
| |||
Postoperative Complication | 0.009 | 2.514 | 1.255 – 5.035 |
Chemotherapy ≥ 8 weeks postoperatively as compared with < 8 weeks
Presence of any of the comorbid conditions listed in Table 2.